Maxim Group is sole placement agent.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AIM:
- AIM ImmunoTech announces publication of clinical study results for AMP-518 trial
- AIM ImmunoTech highlights new article on links between COVID-19, ME/CFS
- AIM ImmunoTech highlights 2024 milestones achieved
- AIM ImmunoTech Executives Forego Bonuses for R&D Focus
- AIM ImmunoTech receives noncompliance notification from NYSE